trending Market Intelligence /marketintelligence/en/news-insights/trending/x8lxryth9b5pr5p5lljgtw2 content esgSubNav
In This List

Eyenovia adds board members

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Eyenovia adds board members

New York's Eyenovia Inc. added Kenneth Lee Jr., Charles Mather IV and Anthony Sun as independent members of its board of directors.

Lee and Sun will serve as chairman of the company's audit committee and compensation committee, respectively.

Lee is a general partner of a venture capital fund called Hatteras Venture Partners, while Mather is the managing director, co-head of equity capital markets at BTIG LLC. Sun held multiple posts at Aisling Capital Management LP, a private equity firm focused on life sciences.

Eyenovia develops therapies for eye diseases.